David Becker, MD, FACC, Director of the Preventive and Integrative Heart Health Program at the Temple Heart and Vascular Institute, wrote a blog post for the Philadelphia Inquirer about the medication Vascepa.
Important announcement concerning Temple Health and Keystone First. Our provider agreement with Keystone First is scheduled to end on July 31st. Click the link below to learn about your options for continuing care at Temple Health.
Learn MoreDavid Becker, MD, FACC, Director of the Preventive and Integrative Heart Health Program at the Temple Heart and Vascular Institute, wrote a blog post for the Philadelphia Inquirer about the medication Vascepa.
Dr. Laura Hart and Dr. Estefania Oliveros, Co-Directors of the Cardio-Obstetrics Program at Temple Health, were featured in a Philadelphia Inquirer article about postpartum heart health.
Read More